• Psoriasis is prevalent in 2-4% of the population in Western countries 1
• Psoriasis is prevalent in 2-4% of the population in Western countries 1 • Longitudinal data on psoriasis patients is continuously collected in the population-based quality registry in Sweden called PsoReg 2
• PsoReg includes patients with moderate to severe psoriasis receiving systemic treatment from a specialist with data available from 2006 to 2014
• Observed and measurable effects affecting quality of life ( ) include PASI, PASI squared, age, body mass index, smoking status, and presence of psoriatic arthritis
• Quality of life is determined, in part, by unobservable effects ( ) like personality
• The model including unobserved effects in Equation 1 cannot be estimated directly since is not observed
• By de-meaning all variables in the model over the time index t (Equation 2), the individual fixed effects are removed, and Equation 3 can be estimated
• By the Frisch-Waugh-Lovell theorem 5, 6 , the coefficient estimates ( ) are numerically equal in Equation 1 and 3. This means that even though is not actually estimated, the coefficients on observed parameters have been adjusted for the effects of
• Psoriasis often results in significant loss to quality of life 3 • This study aims to investigate the relationship between disease severity measured by the psoriasis area severity index (PASI) and quality of life measured by the five dimension European Quality of Life survey (EQ-5D) using the UK-based weighting 4 , = , + + , Equation 1: • An increase in PASI of 10 (20) units results in a decrease in EQ-5D of 0.1571 (0.2717) holding other variables constant at their respective means
• The (adjusted) R 2 was (0.5279) 0.6481 in the regression using a "brute force" method instead of fixed effects
• Figure 1 shows the non-linear relationship in EQ-5D decrement and PASI score, holding all other variables constant 
